The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.
Gerresheimer, a manufacturer of special glass and plastic products to the pharmaceutical industry, has agreed to acquire Sensile Medical AG, an Olten, Switzerland-based medical technology company, in a deal worth up to EUR 350 million ($409...
Sterigenics, a provider of contract sterilization, gamma technologies and medical isotopes, is building a new facility in Markham Vale North in Chesterfield/Derbyshire, UK.
The new 60,000-square-foot facility will include the installation of a...
West Pharmaceutical Services, a manufacturer of packaging and delivery systems for injectable drugs and healthcare products, has opened a new facility in Waterford, Ireland, a global center of excellence for West's manufacturing network, and has...
Cambrex, an East Rutherford, New Jersey-based contract manufacturer of small-molecule active pharmaceutical ingredients (APIs), has agreed to acquire Halo Pharma, a Whippany, New Jersey-headquartered contract development and manufacturing...
PCI Pharma Services, a Philadelphia, Pennsylvania-based pharmaceutical contract service provider, has appointed Salim Haffar, as Chief Executive Officer to take effect later in 2018. Haffar is currently President of Aptar Pharma, a manufacturer of...
AGC, a Tokyo-headquartered manufacturer of glass and chemicals, is planning an expansion of its facilities in Chiba, Japan to increase the company’s manufacturing capacity for pharmaceutical intermediates and active pharmaceutical ingredients...
SK Holdings, a Seoul, South Korea-based holding company of SK Group, has agreed to acquire Ampac Fine Chemicals (AFC), a Rancho Cordova, California-headquartered contract manufacturer of active pharmaceutical ingredients (APIs) and intermediates....
Catalent Pharma Solutions has appointed Marlene Leuenberger as General Manager of the company’s Drug Development Center of Excellence in Somerset, New Jersey.
Leuenberger has over 25 years’ management experience in engineering, quality operations,...
Almac Group, a Craigavon, UK-based contract development and manufacturing organization (CDMO) of active pharmaceutical ingredients (APIs) and drug products, plans to invest £375,000 ($496,000) in additional nuclear magnetic resonance (NMR)...
Catalent Pharma Solutions plans to adopt an optofluidic platform for cell-line development provided by Berkeley Lights (BLI), an Emeryville, California-headquartered company developing platforms for biopharmaceutical processes.
BLI’s Beacon...
Filament BioSolutions, a New York-headquartered development-stage therapeutics company, has formed a collaboration with Ajinomoto Co., a Tokyo, Japan-based manufacturer of amino acids, to develop Filament’s lead product, FB-2710, an oral...
Recipharm, a Jordbro, Sweden-based contract development and manufacturing organization, has launched a stand-alone serialization service for meeting a compliance deadline of February 2019 for certain requirements of the European Union Falsified...
Amphastar Pharmaceuticals, a Rancho Cucamonga, California-based specialty pharmaceutical company, has announced plans to expand the scope of its subsidiary, Amphastar Nanjing Pharmaceuticals (ANP).
Amphastar is a specialty pharmaceutical...
Fermion Oy, a Espoo, Finland-based, a manufacture of small-molecule active pharmaceutical ingredients (APIs), has commissioned a new manufacturing facility in Hanko, Finland, to replace an older manufacturing unit.
Fermion Oy manufacturers APIs...
Evonik has announced plans to invest EUR 35 million ($41 million) to expand its contract development and manufacturing (CDMO) capabilities in North America for controlled-release injectable formulations. The expansion of Evonik’s US and Canadian...
